US Stock MarketDetailed Quotes
PTIX Protagenic Therapeutics
- 0.5900
- -0.0080-1.34%
Close Nov 29 13:00 ET
- 0.5708
- -0.0192-3.25%
Post 16:49 ET
4.01MMarket Cap-464P/E (TTM)
0.6300High0.5500Low115.99KVolume0.6160Open0.5980Pre Close68.41KTurnover2.08%Turnover RatioLossP/E (Static)6.79MShares1.870052wk High5.57P/B3.29MFloat Cap0.490052wk Low--Dividend TTM5.58MShs Float19.5600Historical High--Div YieldTTM13.38%Amplitude0.4900Historical Low0.5890Avg Price1Lot Size
About Protagenic Therapeutics Company
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Company Profile
SymbolPTIX
Company NameProtagenic Therapeutics
Listing DateApr 27, 2021
Issue Price4.50
Founded1994
CEODr. Garo H. Armen, Pd.D
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address149 Fifth Avenue,Suite 500
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-994-8200
Websitehttp://www.protagenic.com
Company Executives
- Name
- Position
- Salary
- Andrew Slee
- Chief Operating Officer
- --
- Dr. Robert B. Stein, M.D.,PhD
- Director and Chief Medical Officer
- --
- Dr. Alexander K. Arrow, M.D.
- Chief Financial Officer
- 150.00K
- Dr. Garo H. Armen, Pd.D
- Executive Chairman of the Board and Principal Executive Officer
- --
- Dr. Jennifer S. Buell, PhD
- Director
- --
- Timothy R. Wright
- Lead Independent Director
- --
- Khalil Barrage
- Independent Director
- --
- Brian J. Corvese
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data